ロード中...
Preclinical evaluation of lestaurtinib (CEP-701) in combination with retinoids for neuroblastoma
PURPOSE: Lestaurtinib (CEP-701), a multi-kinase inhibitor with potent activity against the Trk family of receptor tyrosine kinases, has undergone early phase clinical evaluation in children with relapsed neuroblastoma. We studied the interaction of CEP-701 with isotretinoin (13cRA) and fenretinide (...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4135359/ https://ncbi.nlm.nih.gov/pubmed/21484309 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-011-1623-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|